One more biotechnology company – Sanobiotec, which is engaged in R&D activities, is going to settle down in Vilnius City Innovation Industrial Park. Sanobiotec will start the VCIIP settlement process with the area of 55 ares. The R&D center and administrative premises will open here in 2021. Investments of Sanobiotec will reach 8 mln. euros, about 80 new job openings are planned.